Primary hypertension

Protection from vascular endothelial dysfunction in acute glycemic load-induced primary hypertension by vitamin C and E

J. X. Xu, Su, L., Chen, L., and Lin, J. X., Protection from vascular endothelial dysfunction in acute glycemic load-induced primary hypertension by vitamin C and E, vol. 13, pp. 7246-7255, 2014.

This study aimed to investigate the influence of acute glycemic load on vascular endothelial function in patients with hypertension and to evaluate the protective effect of vitamins C and E during the acute glycemic phase. We randomly selected 39 hypertensive patients and 21 normal subjects and divided them into 3 groups: 75 g oral glucose (glycemic load group), 75 g glucose + 0.9 g vitamin C (VC group), 75 g glucose + 2 g vitamin C + 0.8 g vitamin E (VC + VE group).

Association of the PPARγ2 gene Pro12Ala variant with primary hypertension and metabolic lipid disorders in Han Chinese of Inner Mongolia

L. Gao, Wang, L., Yun, H., Su, L., and Su, X., Association of the PPARγ2 gene Pro12Ala variant with primary hypertension and metabolic lipid disorders in Han Chinese of Inner Mongolia, vol. 9, pp. 1312-1320, 2010.

In order to determine whether Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 (PPARγ2) gene contributes to susceptibility to primary hypertension and metabolic lipid disorders, 482 unrelated subjects from Inner Mongolia were studied, including 137 healthy normotensive (controls) and 345 hypertensive subjects. PCR-RFLP was used to determine the genotypes of Pro12Ala variants of the PPARγ2 gene, and direct sequencing was used to check the results. The frequency of the Ala allele was lower in patients with hypertension (1.3%) than in controls (3.6%).

Subscribe to Primary hypertension